Logistic Regression Analysis Showing OR at 95% CI for Clinically Relevant 18F-DCFPyL PET/CT-Based Features That Predict IBLs as Benign vs. Malignant (n = 79)
| 18F-DCFPyL PET/CT feature | Univariable analysis | Multivariable analysis | ||
|---|---|---|---|---|
| OR | P | OR | P | |
| IBL located in pelvis | 1.68 (0.48–5.96) | 0.516 | — | — |
| IBL located in spine | 1.42 (0.55–3.65) | 0.613 | — | — |
| IBL located in ribs | 0.38 (0.14–1.03) | 0.170 | — | — |
| IBL SUVmax | 9.29 (3.49–24.75) | 0.0016 | 13.87 (1.91–100.9) | 0.0089 |
| Other bone metastases | 9.87 (2.00–48.82) | 0.0112 | 11.35 (3.05–42.25) | 0.0030 |
| Other lymph node metastases | 2.26 (0.62–8.26) | 0.315 | — | — |
Data in parentheses are 95% CI. Features significantly associated with malignant interpretation were included in multivariable analysis.